Vote Scores
Filings read through

How funds voted at Rohto Pharmaceutical Co., Ltd.

Filers reporting
61, year to 30 June 2026
Latest meeting on file
Meetings on file
3

In the year to 30 June 2026, 61 filers on Form N-PX reported votes at Rohto Pharmaceutical Co., Ltd.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 530 marks to the ballot items, each with or against management. 79.6% of the marks are with management.

On say-on-pay, 1 of the 1 reporting filers that marked the item voted against management. This is 100.0% of the filers. Of the reported shares, 100.0% went against management. The median of the 3,799 companies on this site with a say-on-pay item is 6.6% of filers and 2.9% of reported shares.

By filers reporting in the year to 30 June 2026, Rohto Pharmaceutical Co., Ltd. was number 4,705 of 11,972 companies with a page and votes in that year. The number of filers reporting at Rohto Pharmaceutical Co., Ltd. rose by 22.0% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category DIRECTOR ELECTIONS is 73.3% of the vote records at Rohto Pharmaceutical Co., Ltd.. At all companies on this site, it is 52.2%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 24 Jun 2026

61 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    14 nominees. 99.2% of the reported votes are for. 3 filers withheld from or voted against at least one nominee.

    1,218 vote records from 60 filers. 0 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 24
  2. Item 2: Director elections (nominees put forward by security holders)

    1 nominee. 2.4% of the reported votes are for. 53 filers withheld from or voted against at least one nominee.

    83 vote records from 55 filers. 2 of the 55 filers that marked the item voted against management.

    • Positions of 22 fund families
    • Against 22
  3. Item 3: Advisory vote on executive pay (say-on-pay)

    1 vote record from 1 filer. 1 of the 1 filer that marked the item voted against management.

  4. Item 4: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    4 vote records from 4 filers. No filer marked the item for or against management. 4 filers gave no management mark.

    • Positions of 2 fund families
    • Split or no vote 2
  5. Item 5: Amend Articles to Add Provision Concerning Management with Cost of Capital and Share Price Considered

    87 vote records from 60 filers. 8 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 4
    • Against 20
    • Against management 4
  6. Item 6: Amend Articles to Change Record Date for Annual Shareholder Meetings

    87 vote records from 60 filers. 7 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 2
    • Against 22
    • Against management 2
  7. Item 7: Amend Articles to Establish Strategic Review Committee

    87 vote records from 60 filers. 4 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 1
    • Against 23
    • Against management 1
  8. Item 8: Approve Restricted Stock Plan

    87 vote records from 60 filers. 29 of the 60 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 12
    • Against 12
    • Against management 12
  9. Item 9: Initiate Share Repurchase Program

    73 vote records from 53 filers. 2 of the 53 filers that marked the item voted against management.

    • Positions of 21 fund families
    • Against 21
  10. Item 10: Amend Articles to Restore Shareholder Authority to Vote on Income Allocation and Share Buybacks

    65 vote records from 48 filers. 41 of the 48 filers that marked the item voted against management.

    • Positions of 18 fund families
    • For 15
    • Against 3
    • Against management 15
  11. Item 11: Amend Articles to Require Majority Outsider Board

    64 vote records from 47 filers. 4 of the 47 filers that marked the item voted against management.

    • Positions of 18 fund families
    • For 1
    • Against 17
    • Against management 1
  12. Item 12: Shareholder Proposal: Amend Articles of Incorporation (the composition of outside directors)

    22 vote records from 13 filers. 2 of the 13 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 1
    • Against 6
    • Against management 1
  13. Item 13: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    41 vote records from 13 filers. 8 of the 13 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 5
    • Against 1
    • Split or no vote 1
    • Against management 5

Positions of the fund families at the meeting of 24 Jun 2026

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

  • Proposal A: Amend Articles to Add Provision Concerning Management with Cost of Capital and Share Price Considered
  • Proposal B: Amend Articles to Change Record Date for Annual Shareholder Meetings
  • Proposal C: Amend Articles to Establish Strategic Review Committee
  • Proposal D: Approve Restricted Stock Plan
  • Proposal E: Initiate Share Repurchase Program
  • Proposal F: Amend Articles to Restore Shareholder Authority to Vote on Income Allocation and Share Buybacks
  • Proposal G: Amend Articles to Require Majority Outsider Board
  • Proposal H: Shareholder Proposal: Amend Articles of Incorporation (the composition of outside directors)

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Rohto Pharmaceutical Co., Ltd., meeting of 24 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familyProposal AProposal BProposal CProposal DProposal EProposal FProposal GProposal H
American CenturyAgainstAgainstAgainstAgainstAgainstAgainstAgainstNo report
BlackRock and iSharesAgainstAgainstAgainstAgainstNo reportNo reportNo reportAgainst
BNY MellonAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
Charles SchwabFor, against managementAgainstAgainstAgainstAgainstNo reportNo reportAgainst
DimensionalAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
EquitableAgainstAgainstAgainstAgainstAgainstFor, against managementAgainstNo report
FidelityAgainstAgainstAgainstAgainstAgainstFor, against managementAgainstNo report
Franklin TempletonAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
Goldman SachsAgainstFor, against managementAgainstAgainstAgainstFor, against managementAgainstNo report
InvescoAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
Jackson National fundsFor, against managementFor, against managementFor, against managementFor, against managementNo reportNo reportNo reportFor, against management
John Hancock and ManulifeAgainstAgainstAgainstFor, against managementNo reportNo reportNo reportAgainst
Lincoln FinancialAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
MFSAgainstAgainstAgainstAgainstAgainstFor, against managementAgainstNo report
NationwideFor, against managementAgainstAgainstAgainstAgainstNo reportNo reportAgainst
Northern Trust and FlexSharesAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
Nuveen and TIAAAgainstAgainstAgainstAgainstAgainstAgainstAgainstNo report
PIMCOAgainstAgainstAgainstFor, against managementAgainstFor, against managementFor, against managementNo report
SEIFor, against managementAgainstAgainstAgainstAgainstNo reportNo reportAgainst
State Street and SPDRAgainstAgainstAgainstAgainstAgainstFor, against managementAgainstNo report
ThriventAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
TransamericaAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report
VanguardAgainstAgainstAgainstAgainstAgainstAgainstAgainstAgainst
WisdomTreeAgainstAgainstAgainstFor, against managementAgainstFor, against managementAgainstNo report

Every meeting on file

Meetings of Rohto Pharmaceutical Co., Ltd., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 20266113100.0%
year to 30 June 2025505not reported
year to 30 June 2024564not reported

Say-on-pay, season by season

Say-on-pay at Rohto Pharmaceutical Co., Ltd.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202661100.0%100.0%
year to 30 June 202550not reportednot reported
year to 30 June 202456not reportednot reported
Rohto Pharmaceutical Co., Ltd. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against management100.0%6.6%
Reported shares against management100.0%2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Rohto Pharmaceutical Co., Ltd. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS3,47873.3%
SECTION 14A SAY-ON-PAY VOTES10.0%
AUDIT-RELATED400.8%
CAPITAL STRUCTURE1793.8%
COMPENSATION58912.4%
CORPORATE GOVERNANCE4479.4%
OTHER130.3%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Rohto Pharmaceutical Co., Ltd.. https://votescores.com/company/rohto-pharmaceutical-co-ltd/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Rohto Pharmaceutical Co., Ltd. are on file?
3 meetings are on file, from 27 Jun 2024 to 24 Jun 2026. 3 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Rohto Pharmaceutical Co., Ltd.?
Filers reported 8 proposals from security holders that the site could tell apart in the year to 30 June 2026. They fall in 1 meeting. The ballot on this page shows each proposal.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Rohto Pharmaceutical Co., Ltd. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Rohto Pharmaceutical Co., Ltd., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .